Purchase Order AG4232P160020
- Not listed
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a firm fixed price purchase order valued at $4,400.28 for real-time polymerase chain reaction (PCR) services from January 1 through December 31, 2016. The contract was awarded on March 15, 2016, by a civilian federal agency's Southeast Area division, with performance taking place in Fort Pierce, Florida. This award carried no set-aside designation, reflecting the contractor's established competitive position...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $3,703.50 purchase order contract on January 13, 2015, for real-time polymerase chain reaction (PCR) services to be performed in Gainesville, Florida. The contract, which was awarded without set-aside designation, represents a firm fixed-price engagement with an ultimate completion date of January 14, 2017. Funding for this civilian contract was provided by the Southeast Area, a regional office supporting...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a purchase order contract on January 13, 2015, by a civilian federal agency for a service agreement related to a 7500 Fast Real-Time PCR System. The contract, valued at $4,592.24 with a firm fixed price structure, was awarded without set-aside designation and is set to conclude by December 31, 2015. The work will be performed in Fort Pierce, Florida. Life Technologies Corporation is a subsidiary of Thermo...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a delivery order contract on July 31, 2018, for the service and delivery of 7,500 fast real-time PCR (polymerase chain reaction) systems. The contract, valued at $4,470.03 and designated as firm fixed price, was issued without a set-aside designation, reflecting the contractor's competitive standing in federal procurement. The place of performance is located in St. Paul, Minnesota, with an ultimate...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a purchase order by a civilian federal agency's Southeast Area division on January 26, 2016, for the provision of real-time polymerase chain reaction (PCR) machine service and maintenance for 2015-2016 with one additional preventive maintenance visit at $3,018.68. The contract, which is not subject to any set-aside designation, carries a ceiling value of $7,418.80 and operates under firm fixed-price terms,...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a delivery order contract from a civilian federal agency's Southeast Area office on December 23, 2016, for real-time PCR services valued at $4,488.28. The contract was awarded without set-aside designation under a firm fixed price arrangement and was completed by September 21, 2020. As a leading manufacturer of scientific instruments, reagents, and consumables, Life Technologies has established itself as a key...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a firm fixed-price purchase order by a civilian federal agency's Southeast Area division on November 19, 2015, for a real-time PCR system service agreement. The contract, valued at $4,400.28, covers the 12-month performance period from December 21, 2015, through December 20, 2016, with the place of performance located in Stoneville, Mississippi. This award was made without a set-aside designation, reflecting...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a purchase order contract on July 31, 2015, for AB17500 Fast Real Time PCR System Service Contract valued at $4,014.72. The contract is a firm fixed-price award with an ultimate completion date of November 4, 2016, and was funded through a civilian federal agency's Midwest Area office. The place of performance is located in Carlsbad, California. No set-aside designation was applied to this award, reflecting...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $4,877.28 firm fixed price purchase order by a civilian federal agency (Midwest Area) on August 2, 2017, for service agreement on a 7500 FAST Real Time PCR System. The contract, which was not set aside for small businesses, is scheduled for completion by July 31, 2018, with performance taking place in West Lafayette, Indiana. This award represents a routine procurement of maintenance or support services...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $27,395.63 firm fixed-price delivery order for a real-time PCR thermocycler on September 23, 2019, with an ultimate completion date of September 21, 2020. The contract, which carries no set-aside designation, was funded by a civilian federal agency and calls for performance in Carlsbad, California. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation and serves as a leading supplier...
Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $4,591.96 firm fixed-price purchase order for fast real-time polymerase chain reaction (PCR) services by a civilian federal agency in the Southeast Area. The contract commenced on January 1, 2016, with an ultimate completion date of January 31, 2017, and was awarded on January 26, 2016, without a set-aside designation. Performance of the services was to occur in Fort Pierce, Florida. Real-time PCR is a molecular biology technique widely used by federal research and public health agencies, including the Centers for Disease Control and Prevention and National Institutes of Health, for genetic analysis, pathogen detection, and diagnostic applications. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, is a prominent supplier of scientific instruments and laboratory services to federal agencies across multiple sectors. The company's portfolio includes genetic analyzers, sequencing systems, and related reagents and consumables that support advanced research and operational capabilities. This purchase order reflects the company's established competitive position in federal procurement for specialized biotechnology services and aligns with typical federal agency requirements for molecular diagnostics and research support across civilian and defense-related programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/26/16 |